Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Karin Povlsen1, Kenneth Skov1,2, Miriam Kolko2,3,4

  • 1Klinisk Farmakologisk Enhed, Sjællands Universitetshospital, Roskilde.

Ugeskrift for Laeger
|November 29, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking Dry Eye and Ocular Surface Disesase in Glaucoma: Pathophysiology, Diagnosis, and Management.

Journal of glaucoma·2026
Same author

Rethinking Dry Eye and Ocular Surface Disease in Glaucoma: Pathophysiology, Diagnosis, and Management.

Journal of glaucoma·2026
Same author

Geographic Disparities in Access to Glaucoma Surgery: Lessons from a Nationwide Registry Study.

Journal of clinical medicine·2026
Same author

Detection of age-related vision reduction in general practice in Denmark (DETECT): a study protocol for a feasibility and cohort study.

BMJ open·2026
Same author

Intraocular Pressure During Short-Term Topical or Systemic Corticosteroid Treatment: Analysis of 3 Randomized Clinical Trials.

JAMA dermatology·2026
Same author

Optimizing topical glaucoma treatment outcomes: When less is better. A review on the clinical benefits of reducing treatment burden in glaucoma management.

European journal of ophthalmology·2026

Psychotropic medications can trigger angle-closure glaucoma in susceptible patients. Careful ophthalmological monitoring is crucial for those exposed, especially when using certain antidepressants and antipsychotics.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Neuroscience

Background:

  • Psychotropic medications are widely prescribed for various mental health conditions.
  • Glaucoma, particularly angle-closure glaucoma, poses a significant risk to vision.
  • The interaction between psychotropic drug use and glaucoma requires careful consideration.

Approach:

  • This review synthesizes current research on the relationship between psychotropic drugs and glaucoma.
  • It examines specific drug classes, including antidepressants, benzodiazepines, and antipsychotics.
  • The review highlights the importance of ophthalmological surveillance in at-risk populations.

Key Points:

  • Certain psychotropic drugs can precipitate angle-closure glaucoma in predisposed individuals.

Related Experiment Videos

  • Tricyclic antidepressants and benzodiazepines warrant cautious use in patients with glaucoma risk factors.
  • First-generation antipsychotics may have a lesser impact on intraocular pressure compared to second-generation agents.

    • Conclusions:

    • Patients exposed to psychotropic drugs who are predisposed to or diagnosed with glaucoma require vigilant ophthalmological follow-up.
    • The risk of angle-closure glaucoma associated with serotonin reuptake inhibitors remains under investigation.
    • Prudent prescribing practices and patient monitoring are essential to mitigate risks.